Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Maastricht University Medical Center
Maastricht University Medical Center
Massachusetts General Hospital
UNICANCER
Seoul National University Hospital
University of Cincinnati
Jules Bordet Institute
University of California, San Diego
Seoul National University Hospital
Institut Català d'Oncologia
Radboud University Medical Center
Gustave Roussy, Cancer Campus, Grand Paris
Azienda Ospedaliero-Universitaria Careggi